239 related articles for article (PubMed ID: 30578968)
1. Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis.
Li Y; Xie H; Deng Z; Wang B; Tang Y; Zhao Z; Yuan X; Zuo Z; Xu S; Zhang Y; Li J
Int Immunopharmacol; 2019 Feb; 67():326-334. PubMed ID: 30578968
[TBL] [Abstract][Full Text] [Related]
2. Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea.
Yuan X; Li J; Li Y; Deng Z; Zhou L; Long J; Tang Y; Zuo Z; Zhang Y; Xie H
Biomed Pharmacother; 2019 Sep; 117():109181. PubMed ID: 31387196
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.
Chen M; Xie H; Chen Z; Xu S; Wang B; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Li J; Deng Z
Biomed Pharmacother; 2019 Aug; 116():109011. PubMed ID: 31132668
[TBL] [Abstract][Full Text] [Related]
4. Aspirin alleviates skin inflammation and angiogenesis in rosacea.
Deng Z; Xu S; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Wang B; Xie H; Chen M; Li J
Int Immunopharmacol; 2021 Jun; 95():107558. PubMed ID: 33743316
[TBL] [Abstract][Full Text] [Related]
5. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
Front Immunol; 2021; 12():609615. PubMed ID: 34322115
[TBL] [Abstract][Full Text] [Related]
6. Colchicine Alleviates Rosacea by Inhibiting Neutrophil Inflammation Activated by the TLR2 Pathway.
Yuan X; Sheng L; Shi G; Jiang L; Lian C
Inflammation; 2024 Jun; 47(3):1002-1014. PubMed ID: 38279067
[TBL] [Abstract][Full Text] [Related]
7. Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2/MyD88/NF-κB pathway.
Shen S; Yan G; Cao Y; Zeng Q; Zhao J; Wang X; Wang P
Biomed Pharmacother; 2023 Jan; 157():114091. PubMed ID: 36481403
[TBL] [Abstract][Full Text] [Related]
8. Activation of aryl hydrocarbon receptor ameliorates rosacea-like eruptions in mice and suppresses the TLR signaling pathway in LL-37-induced HaCaT cells.
Sun Y; Chen L; Wang H; Zhu P; Jiang S; Qi R; Wu Y; Gao X
Toxicol Appl Pharmacol; 2022 Sep; 451():116189. PubMed ID: 35926563
[TBL] [Abstract][Full Text] [Related]
9. Exploring metformin as a candidate drug for rosacea through network pharmacology and experimental validation.
Li Y; Yang L; Wang Y; Deng Z; Xu S; Xie H; Zhang Y; Li J
Pharmacol Res; 2021 Dec; 174():105971. PubMed ID: 34763093
[TBL] [Abstract][Full Text] [Related]
10.
Roh KB; Ryu DH; Cho E; Weon JB; Park D; Kweon DH; Jung E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33256158
[TBL] [Abstract][Full Text] [Related]
11. Celastrol inhibits LL37-induced rosacea by inhibiting Ca
Zeng Q; Yang J; Yan G; Zhang L; Wang P; Zhang H; Chen Q; Cao Y; Liu X; Wang X
Biomed Pharmacother; 2022 Sep; 153():113292. PubMed ID: 35717785
[TBL] [Abstract][Full Text] [Related]
12. Intradermal tranexamic acid microinjections: a novel treatment option for erythematotelangiectatic rosacea.
Daadaa N; Litaiem N; Karray M; Bacha T; Jones M; Belajouza Noueiri C; Goucha S; Zeglaoui F
J Cosmet Dermatol; 2021 Oct; 20(10):3324-3329. PubMed ID: 33973361
[TBL] [Abstract][Full Text] [Related]
13. Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea.
Kim M; Kim KE; Jung HY; Jo H; Jeong SW; Lee J; Kim CH; Kim H; Cho D; Park HJ
Exp Dermatol; 2015 Sep; 24(9):680-5. PubMed ID: 25940661
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive treatment for acne vulgaris by tranexamic acid.
Charoenwattanayothin A; Saiwichai T; Chaichalotornkul S
J Cosmet Dermatol; 2022 Oct; 21(10):4515-4522. PubMed ID: 35388589
[TBL] [Abstract][Full Text] [Related]
15. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.
Coda AB; Hata T; Miller J; Audish D; Kotol P; Two A; Shafiq F; Yamasaki K; Harper JC; Del Rosso JQ; Gallo RL
J Am Acad Dermatol; 2013 Oct; 69(4):570-7. PubMed ID: 23871720
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of IL-33 in rosacea skin and UVB-irradiated and LL-37-treated HaCaT cells.
Suhng E; Kim BH; Choi YW; Choi HY; Cho H; Byun JY
Exp Dermatol; 2018 Sep; 27(9):1023-1029. PubMed ID: 29873850
[TBL] [Abstract][Full Text] [Related]
17. A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea.
Deng Z; Chen M; Liu Y; Xu S; Ouyang Y; Shi W; Jian D; Wang B; Liu F; Li J; Shi Q; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Zhang H; Wang Q; Sun L; Xie H; Li J
EMBO Mol Med; 2021 May; 13(5):e13560. PubMed ID: 33734592
[TBL] [Abstract][Full Text] [Related]
18. Oral tranexamic acid treats papulopustular rosacea by improving the skin barrier.
Xu Z; Yu B; Xu B; Ye S; Qing Y; Zhao B; Hong S; Wu N; Wu J
J Cosmet Dermatol; 2024 May; ():. PubMed ID: 38712728
[TBL] [Abstract][Full Text] [Related]
19. Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea.
Zhang J; Xu X; Rao NV; Argyle B; McCoard L; Rusho WJ; Kennedy TP; Prestwich GD; Krueger G
PLoS One; 2011 Feb; 6(2):e16658. PubMed ID: 21347371
[TBL] [Abstract][Full Text] [Related]
20. Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model.
Diebel LN; Martin JV; Liberati DM
J Trauma Acute Care Surg; 2017 Jun; 82(6):1080-1086. PubMed ID: 28328682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
